Breaking News Instant updates and real-time market news.

PENN

Penn National

, WYNN

Wynn Resorts

$145.92

0.02 (0.01%)

14:03
09/13/17
09/13
14:03
09/13/17
14:03

NJ reports August gaming revenue down 0.4% to $244.8M

New Jersey's Division of Gaming Enforcement reported that casino win from the industry was $223.6M, compared to $229.8M in August 2016, reflecting a 2.7% decrease. Internet gaming win was $21.3M, compared to $16.1M in the prior period, reflecting an increase of 32.4%. The industry's total gaming win for the month was $244.8M, compared to $245.9M for August 2016, reflecting a 0.4% decrease. Publicly traded companies in the casino gaming space include Boyd Gaming (BYD), Caesars (CZR), Las Vegas Sands (LVS), MGM Resorts (MGM), Penn National (PENN) and Wynn Resorts (WYNN).

PENN

Penn National

WYNN

Wynn Resorts

$145.92

0.02 (0.01%)

BYD

Boyd Gaming

$26.40

-0.3 (-1.12%)

MGM

MGM Resorts

$32.70

-0.05 (-0.15%)

CZR

Caesars

LVS

Las Vegas Sands

$64.62

0.139 (0.22%)

  • 02

    Oct

PENN Penn National

07/28/17
STFL
07/28/17
NO CHANGE
STFL
Penn National shares should be bought on weakness, says Stifel
Stifel analyst Steven Wieczynski recommends buying Penn on weakness as he thinks that improvements in the company's "core underlying business" will boost the stock over the near-term.
01/27/17
BUCK
01/27/17
INITIATION
Target $17
BUCK
Buy
Penn National initiated with a Buy at Buckingham
Buckingham analyst Christopher Jones initiated Penn National with a Buy and a $17 price target Target $17 saying FY17 should be good for PENN as it will be the first year it enjoys all the benefits of recent initiatives and investments.
02/09/17
RHCO
02/09/17
INITIATION
Target $14
RHCO
Hold
Penn National initiated with a Hold at SunTrust
SunTrust initiated Penn National with a Hold and a $14 price target.
04/27/17
DBAB
04/27/17
NO CHANGE
Target $22
DBAB
Buy
Penn National selloff 'makes little sense,' says Deutsche Bank
Deutsche Bank analyst Carlo Santarelli says today's post-earnings selloff in shares of Penn National Gaming "makes little sense." He views the company's earnings report as solid and attributes the share weakness to "trading oriented positioning." The analyst sees 20% upside from current levels and recommends buying Penn shares. Santarelli has a Buy rating on the name with a $22 price target.
WYNN Wynn Resorts
$145.92

0.02 (0.01%)

07/26/17
07/26/17
DOWNGRADE

Market Perform
Update: Wynn Resorts downgraded to Market Perform at Telsey Advisory
As previously reported, Telsey Advisory downgraded Wynn Resorts to Market Perform from Outperform and maintained a $150 price target. Analyst David Katz said the execution of the Palace opening has not been what he expected and believes the Macau market is facing increasingly challenging comps starting in Q3 and beyond. Katz ultimately believes the Palace will achieve its objectives and the overall Wynn thesis remains intact, but views visibility as limited over the next several quarters.
07/26/17
UGAM
07/26/17
DOWNGRADE
UGAM
Hold
Wynn Resorts downgraded to Hold from Buy at Union Gaming
07/26/17
07/26/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. AMD (AMD) downgraded to Market Perform from Outperform at BMO Capital. 2. Zoetis (ZTS) downgraded to Hold from Buy at Deutsche Bank with analyst Gregg Gilbert saying the risk/reward is more balanced with the shares up 18% year-to-date. 3. CF Industries (CF) downgraded to Neutral from Outperform at Credit Suisse with analyst Christopher Parkinson citing the recent rally in shares. 4. Eli Lilly (LLY) downgraded to Market Perform from Outperform at Leerink with analyst Seamus Fernandez saying that the regulatory update for Olumiant removes upside optionality in rheumatoid arthritis and possibly other indications given concerns over thrombosis risk. 5. Wynn Resorts (WYNN) was downgraded to Hold from Buy at Union Gaming and to Market Perform from Outperform at Telsey Advisory. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/15/17
DBAB
08/15/17
UPGRADE
Target $150
DBAB
Buy
Wynn Resorts upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Carlo Santarelli upgraded Wynn Resorts to Buy and raised his price target for the shares to $150 from $138. The analyst believes the mass ramp at Wynn Palace is beginning to accelerate and that current share levels represent a favorable entry point.
BYD Boyd Gaming
$26.40

-0.3 (-1.12%)

07/28/17
DBAB
07/28/17
NO CHANGE
Target $29
DBAB
Buy
Boyd Gaming weakness a buying opportunity, says Deutsche Bank
Deutsche Bank analyst Carlo Santarelli says he's a buyer of Boyd Gaming on any post-earnings weakness. While expectations were slightly elevated, Boyd's adjusted EBITDA miss relative to consensus is more a communication lapse than an operational breakdown, Santarelli tells investors in a post-earnings research note. The analyst believes the "key merits of the story remain firm." He keeps a Buy rating on the shares and lowered his price target for the shares to $29 from $30.
06/20/17
06/20/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Philips (PHG) downgraded to Hold from Buy at Deutsche Bank with analyst Gael de-Bray citing valuation with the stock up 52% over the past year. 2. Comcast (CMCSA) downgraded to Neutral from Buy at MoffettNathanson with analyst Craig Moffett saying stocks have had a multi-year bull run and air fairly valued. 3. ADP (ADP) was downgraded to Neutral from Conviction Buy and Paychex (PAYX) was downgraded to Neutral from Buy at Goldman Sachs. 4. Boyd Gaming (BYD) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Thomas Allen saying risk/reward is more balanced following the recent strength in shares. 5. Cheesecake Factory (CAKE) downgraded to Hold from Buy at Argus with analyst John Staszak citing the company's reduction in its second quarter same-store sales guidance from an increase of 0.5%-1.5% to a decline of 1%. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/20/17
06/20/17
DOWNGRADE
Target $26

Equal Weight
Boyd Gaming downgraded to Equal Weight on valuation at Morgan Stanley
As previously reported, Morgan Stanley downgraded Boyd Gaming to Equal Weight from Overweight and raised its price target to $26 from $23. Analyst Thomas Allen said risk/reward is more balanced following the recent strength in shares.
06/20/17
MSCO
06/20/17
DOWNGRADE
MSCO
Equal Weight
Boyd Gaming downgraded to Equal Weight from Overweight at Morgan Stanley
MGM MGM Resorts
$32.70

-0.05 (-0.15%)

08/01/17
UBSW
08/01/17
DOWNGRADE
Target $36
UBSW
Neutral
MGM Resorts downgraded to Neutral from Buy at UBS
UBS analyst Robin Farley downgraded MGM Resorts to Neutral while raising her price target for the shares to $36 from $33. The current valuation, with the shares up 37% over the past 12 months, now captures much of the value of the REIT transaction and improving Las Vegas outlook, Farley tells investors in a research note.
08/01/17
08/01/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. MGM Resorts (MGM) downgraded to Neutral from Buy at UBS with analyst Robin Farley saying the current valuation, with the shares up 37% over the past 12 months, now captures much of the value of the REIT transaction and improving Las Vegas outlook. 2. Boardwalk Pipeline (BWP) downgraded to Sector Perform from Outperform at RBC Capital with analyst Elvira Scotto saying she expects the stock to be "range bound" until its 2019-2020 outlook become clearer. 3. La-Z-Boy (LZB) downgraded to Neutral from Buy at Sidoti with analyst Anthony Lebiedzinski saying shares are approaching his $36 price target. 4. Regeneron (REGN) downgraded to Underperform from Neutral at Baird with analyst Brian Skorney saying Dupixent expectations have gotten ahead of themselves and consensus numbers currently reflect an overlap with Cosentyx sales which looks like an overestimate. 5. Corporate Office Properties (OFC) downgraded to Sell from Hold at Stifel with analyst John Guinee saying he believes that the Real Estate Investment Trust will be hurt by "persistently weak leasing economics," the expirations of a large number of its leases with high rents, and efforts by defense and IT organization to keep rent costs low. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/08/17
JPMS
09/08/17
NO CHANGE
Target $39
JPMS
Overweight
National Harbor deal positive for MGM, MGM Growth, says JPMorgan
JPMorgan analyst Joseph Greff has a favorable view of both MGM Resorts (MGM) and MGM Growth Properties (MGP) as it relates to the purchase of MGM National Harbor's real estate for $1.1875B. For MGM Growth, the deal is accretive and represents a good valuation multiple, Greff tells investors in a research note. He upped his price target for the shares to $33 from $31. For MGM, the transaction improves the balance sheet and helps accelerate the return of capital via a $1B share repurchase authorization, the analyst writes. He upped his price target for those shares to $39 from $37. He keeps Overweight ratings on both stocks.
09/11/17
DBAB
09/11/17
DOWNGRADE
Target $36
DBAB
Hold
MGM Resorts downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Carlo Santarelli downgraded MGM Resorts to Hold while maintaining a $36 price target on the shares. The continued slowing of Las Vegas Strip EBITDA growth will likely pressure trading multiples, Santarelli tells investors in a research note. He believes Las Vegas Strip fundamentals are "exhibiting late cycle tendencies."
CZR Caesars

06/01/17
06/01/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Pentair (PNR) reinstated with a Sell at Goldman Sachs. 2. Global Payments (GPN) coverage resumed with a Buy at Stifel. 3. Caesars (CZR) initiated with an Outperform at Oppenheimer. 4. Resolute Energy (REN) initiated with a Buy at SunTrust. 5. Ziopharm (ZIOP) initiated with a Buy at H.C. Wainwright. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/19/17
IMPC
07/19/17
INITIATION
Target $15
IMPC
Outperform
Caesars re-initiated with an Outperform at Imperial Capital
Imperial Capital analyst Gregg Klein re-initiated coverage of Caesars Entertainment with an Outperform rating and $15 price target. The analyst says his price target is based on the sum-of-the-parts analysis of the company's three wholly-owned subsidiaries. As Caesars exists today, the shares are worth around $14, Klein contends.
07/19/17
07/19/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tyson Foods (TSN) reinstated with a Neutral at Credit Suisse. 2. Bob Evans (BOBE) initiated with a Buy at Berenberg. 3. Quanex (NX) coverage assumed with an Outperform at Wedbush. 4. Agile Therapeutics (AGRX) initiated with a Buy at H.C. Wainwright. 5. Caesars (CZR) re-initiated with an Outperform at Imperial Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/21/17
WOLF
07/21/17
INITIATION
Target $16
WOLF
Outperform
Caesars initiated with an Outperform at Wolfe Research
Wolfe initiated Caesars with an Outperform and a $16 price target.
LVS Las Vegas Sands
$64.62

0.139 (0.22%)

05/19/17
JPMS
05/19/17
NO CHANGE
JPMS
Macau gaming regulator comments 'nothing new,' says JPMorgan
After local Chinese media quoted Paulo Chan, the director of Macau's gaming regulator, as having said that existing casino operators will have to "re-bid" for their concessions, JP Morgan analyst DS Kim said earlier that "this is nothing new" as he believes Chan was just clarifying legal terminology and statutory facts. Chan emphasized there isn't any new development regarding gaming concessions, which Kim thinks is the message he wanted to convey. Kim also said in a note issued prior to the open that his view remains that all six existing licenses will be renewed and no new license will be issued.
06/12/17
TLSY
06/12/17
NO CHANGE
TLSY
Macau estimates should continue to move higher, says Telsey Advisory
Telsey Advisory's contacts indicate the first 11 days of June's results indicate growth year-over-year of 29%-31% for the month, which is better than expected and supports the firm's view that estimates will continue to move higher heading into the quarterly reporting season. Telsey's analyst continues to see better leverage for Outperform rated Wynn Resorts (WYNN), with MGM Resorts (MGM) and Las Vegas Sands (LVS) also as beneficiaries.
07/17/17
GSCO
07/17/17
NO CHANGE
GSCO
Goldman says capital flow scrutiny could hurt sentiment on Macau gaming names
Goldman Sachs analyst Simon Cheung noted reports that Macau's largest junket operator has distributed a memo to its customers advising that police have launched large-scale investigations into questionable cross-border money transfers. To avoid scrutiny, some players may gamble less, which could hurt gross gaming revenue momentum in the near-term, Cheung tells investors. More important, perhaps, will be whether this issue will structurally impair the money transfer mechanism and that investors may become more concerned about the space. Publicly traded companies in the Macau gaming space include Las Vegas Sands (LVS), MGM Resorts (MGM), Wynn Resorts (WYNN) and Melco Resorts (MLCO).
07/18/17
STFL
07/18/17
NO CHANGE
STFL
Las Vegas Sands weakness creates buying opportunity, says Stifel
Stifel analyst Steven Wieczynski raised his estimates on Las Vegas Sands by about 4%, citing positive trends he's seen in Macau in the last six months and his belief that "Macau's fundamentals should continue to improve." The analyst says that the non-VIP trends in Macau continue to be strong and he thinks they "will remain healthy for the foreseeable future." He thinks that the recent pullback in the stock has created a buying opportunity.

TODAY'S FREE FLY STORIES

UNH

UnitedHealth

$232.90

4.26 (1.86%)

20:31
01/16/18
01/16
20:31
01/16/18
20:31
Recommendations
UnitedHealth analyst commentary  »

UnitedHealth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

AVXS

AveXis

$105.01

-12.49 (-10.63%)

20:31
01/16/18
01/16
20:31
01/16/18
20:31
Syndicate
AveXis 3.921M share Secondary priced at $102.00 »

Goldman Sachs, Jefferies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

OZRK

Bank of the Ozarks

$52.23

-0.24 (-0.46%)

20:26
01/16/18
01/16
20:26
01/16/18
20:26
Downgrade
Bank of the Ozarks rating change  »

Bank of the Ozarks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 30

    Jan

WP

Worldpay

$78.26

0.66 (0.85%)

, VNTV

Symbol changed to WP

20:25
01/16/18
01/16
20:25
01/16/18
20:25
Initiation
Worldpay, Symbol changed to WP initiated  »

Worldpay reinstated with…

WP

Worldpay

$78.26

0.66 (0.85%)

VNTV

Symbol changed to WP

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$31.24

0.05 (0.16%)

, GS

Goldman Sachs

$258.46

1.43 (0.56%)

20:25
01/16/18
01/16
20:25
01/16/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

BAC

Bank of America

$31.24

0.05 (0.16%)

GS

Goldman Sachs

$258.46

1.43 (0.56%)

USB

U.S. Bancorp

$57.17

0.19 (0.33%)

FAST

Fastenal

$55.44

-0.15 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 18

    Jan

  • 31

    Jan

  • 15

    Feb

C

Citi

$77.11

0.27 (0.35%)

20:20
01/16/18
01/16
20:20
01/16/18
20:20
Downgrade
Citi rating change  »

Citi downgraded to Market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 18

    Jan

  • 24

    Jan

O

Realty Income

$52.94

0.22 (0.42%)

19:12
01/16/18
01/16
19:12
01/16/18
19:12
Hot Stocks
Realty Income raises monthly dividend to 21.9c per share from 21.25c »

Realty Income announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NGD

New Gold

$3.44

0.05 (1.47%)

19:05
01/16/18
01/16
19:05
01/16/18
19:05
Hot Stocks
New Gold sees FY18 gold production 525,000-595,000 ounces »

Sees FY18 copper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NGD

New Gold

$3.44

0.05 (1.47%)

19:04
01/16/18
01/16
19:04
01/16/18
19:04
Hot Stocks
New Gold reports Q4 gold production 154,446 ounces »

Reports Q4 copper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NGD

New Gold

$3.44

0.05 (1.47%)

19:04
01/16/18
01/16
19:04
01/16/18
19:04
Hot Stocks
New Gold reports FY17 gold production 430,864 ounces »

Reports FY17 copper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$80.42

-0.12 (-0.15%)

18:50
01/16/18
01/16
18:50
01/16/18
18:50
Earnings
PayPal sees FY18 revenue $15B-$15.25B, consensus $15.35B »

Backs FY18 TPV Growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

CE

Celanese

$109.67

-1.67 (-1.50%)

18:32
01/16/18
01/16
18:32
01/16/18
18:32
Hot Stocks
Celanese increases the price of low density polyethylene to 4c »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jan

RIG

Transocean

$11.47

-0.73 (-5.98%)

18:27
01/16/18
01/16
18:27
01/16/18
18:27
Hot Stocks
Transocean shareholders show 'overwhelming support' for Songa transaction »

Transocean announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

WMT

Walmart

$100.69

-0.18 (-0.18%)

18:13
01/16/18
01/16
18:13
01/16/18
18:13
Periodicals
Wal-Mart COO to be named international CEO, Reuters says »

Wal-Mart Stores COO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

CME

CME Group

$152.20

-0.53 (-0.35%)

18:05
01/16/18
01/16
18:05
01/16/18
18:05
Hot Stocks
CME reaches daily trading volume record for Henry Hub Nat Gas futures on Jan 12 »

CME Group announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 01

    Feb

CE

Celanese

$109.67

-1.67 (-1.50%)

18:02
01/16/18
01/16
18:02
01/16/18
18:02
Hot Stocks
Celanese announces price increases for engineered materials polymer products »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jan

SRC

Spirit Realty

$8.07

-0.03 (-0.37%)

17:46
01/16/18
01/16
17:46
01/16/18
17:46
Hot Stocks
Spirit Realty funds $35M into Shopko master lease »

Spirit Realty Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTNX

Nutanix

$36.01

-1.83 (-4.84%)

17:45
01/16/18
01/16
17:45
01/16/18
17:45
Conference/Events
Nutanix management to meet with Piper Jaffray »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

, CELG

Celgene

$104.82

-1.18 (-1.11%)

17:41
01/16/18
01/16
17:41
01/16/18
17:41
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Juno Therapeutics…

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

CELG

Celgene

$104.82

-1.18 (-1.11%)

NEWA

Newater Technology

$15.80

2.8 (21.54%)

VRS

Verso

$17.00

0.06 (0.35%)

EXEL

Exelixis

$29.65

-0.73 (-2.40%)

IPSEY

Ipsen

RNST

Renasant

$43.86

0.15 (0.34%)

IBKR

Interactive Brokers

$62.45

-0.65 (-1.03%)

CSX

CSX

$58.13

-1.12 (-1.89%)

ATEN

A10 Networks

$7.31

-0.27 (-3.56%)

HTGM

HTG Molecular

$3.50

-0.14 (-3.85%)

HIVE

Aerohive

$5.70

-0.19 (-3.23%)

OBLN

Obalon Therapeutics

$7.93

0.03 (0.38%)

XON

Intrexon

$13.77

-0.94 (-6.39%)

BOOT

Boot Barn

$19.10

-0.15 (-0.78%)

F

Ford

$13.10

-0.13 (-0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 16

    Jan

  • 16

    Jan

  • 17

    Jan

  • 18

    Jan

  • 19

    Jan

  • 19

    Jan

  • 24

    Jan

  • 25

    Jan

  • 25

    Jan

  • 08

    Feb

  • 08

    Feb

  • 15

    Feb

  • 16

    Feb

  • 26

    Feb

  • 01

    Mar

  • 25

    Mar

  • 17

    Jan

  • 18

    Jan

  • 19

    Jan

  • 19

    Jan

NRZ

New Residential

$17.63

-0.11 (-0.62%)

17:35
01/16/18
01/16
17:35
01/16/18
17:35
Earnings
Breaking Earnings news story on New Residential »

New Residential sees Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

EXEL

Exelixis

$29.65

-0.73 (-2.40%)

17:30
01/16/18
01/16
17:30
01/16/18
17:30
Hot Stocks
Breaking Hot Stocks news story on Exelixis »

Exelixis up 3.2%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 19

    Jan

  • 19

    Jan

  • 25

    Jan

  • 08

    Feb

  • 15

    Feb

EXEL

Exelixis

$29.65

-0.73 (-2.40%)

17:30
01/16/18
01/16
17:30
01/16/18
17:30
Hot Stocks
Breaking Hot Stocks news story on Exelixis 

Exelixis trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 19

    Jan

  • 19

    Jan

  • 25

    Jan

  • 08

    Feb

  • 15

    Feb

CELG

Celgene

$104.82

-1.18 (-1.11%)

, JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

17:27
01/16/18
01/16
17:27
01/16/18
17:27
Periodicals
Celgene in discussions to acquire Juno Therapeutics, WSJ reports »

Celgene (CELG) is in…

CELG

Celgene

$104.82

-1.18 (-1.11%)

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

17:25
01/16/18
01/16
17:25
01/16/18
17:25
Conference/Events
CFA Society of New York to hold a discussion »

The CFA Society of New…

YUMA

Yuma Energy

$1.49

-0.14 (-8.59%)

17:21
01/16/18
01/16
17:21
01/16/18
17:21
Syndicate
Breaking Syndicate news story on Yuma Energy »

Yuma Energy files $75M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.